Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
2.080
+0.240 (13.04%)
At close: Nov 21, 2024, 4:00 PM
2.000
-0.080 (-3.84%)
After-hours: Nov 21, 2024, 5:58 PM EST

Quince Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
9245233778191,507
Upgrade
Market Cap Growth
-17.57%95.46%-93.89%-53.99%-45.64%-
Upgrade
Enterprise Value
48-38-712646821,387
Upgrade
Last Close Price
1.841.050.6412.6227.7856.14
Upgrade
PB Ratio
1.760.530.233.184.7613.05
Upgrade
P/TBV Ratio
-11.890.243.184.7613.05
Upgrade
Debt / Equity Ratio
0.340.160.000.010.00-
Upgrade
Quick Ratio
8.827.9529.717.597.8711.23
Upgrade
Current Ratio
9.538.0930.557.858.1111.93
Upgrade
Return on Equity (ROE)
-83.18%-33.81%-47.14%-61.85%-53.42%-39.57%
Upgrade
Return on Assets (ROA)
-18.82%-11.33%-26.40%-34.99%-31.42%-24.82%
Upgrade
Return on Capital (ROIC)
-27.80%-15.41%-28.36%-38.60%-34.22%-26.20%
Upgrade
Earnings Yield
-58.76%-69.73%-224.32%-23.85%-9.38%-2.45%
Upgrade
FCF Yield
-33.73%-40.99%-191.80%-16.74%-6.21%-2.21%
Upgrade
Buyback Yield / Dilution
-18.71%-11.17%-12.71%-1.86%-53.30%-466.06%
Upgrade
Total Shareholder Return
-18.71%-11.17%-12.71%-1.86%-53.30%-466.06%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.